Colgate-Palmolive Company company logo

# 1st Gen Model Colgate-Palmolive Company Toilet preparations

Subscribe >> Deal exit on
Dec. 18, 2017
68.09% successful of 47 deals
$74.05 Last close price
at 15-dec-2017

CL

Model's trade recommendations 0.71% Return for period

2.77% Annual return

$64.41B Market Cap

β 0.81  

CL

Model (following trade recommendations)

CL

Underlying stock

S&P 500

Index
Return for period 0.71%
3.00%
1.78%
52wk return 3.13%
11.81%
16.82%
52wk Range
64.53—77.23
2000.54—2399.63
Sortino ratio 0.83
Sharpe ratio 0.58
Norm. RMSE 0.19%
Downside risk 3.01%
Volatility 4.30%
  • 1.60 (2.18%) Div (Yield)
  • HOLD Analysts consensus recommendation

Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. As a leading consumer products company, they are also deeply committed to advancing technology that can address changing consumer needs throughout the world. In fact, their goal is to use technology to create products that will continue to improve the quality of life for consumers where they live.

Industry sector: Consumer Staples

Sector classification: Toilet preparations

Deep Learning based analysis and prediction model for Colgate-Palmolive Company (CL) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CL model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 869M
P/E 25.56
Shares Outstanding 878M
% Held by Insiders 1.02%
% Held by Institutions 72.96%
EPS (last reported FY) $2.81
EPS (last reported Q) $0.73
EPS, estimated (last reported Q) $0.73
Total revenues $15 B
Net income $2 B